FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Caribbean

  • Home
  •  | 
  • Tag Archives: "Caribbean"

GSRX Industries Inc. Requests Final Inspection of New Medicinal Cannabis Dispensary in Fajardo, Puerto Rico

GSRX Industries Inc. Requests Final Inspection of New Medicinal Cannabis Dispensary in Fajardo, Puerto Rico
DORADO, Puerto Rico, Oct. 03, 2018 (GLOBE NEWSWIRE) -- GSRX Industries Inc. (OTCQB: GSRX) (“GSRX” or, the “Company”), through its wholly-owned subsidiary, Project 1493 LLC, announced today that it has requested final inspection of its pre-qualified medicinal cannabis dispensary located in Fajardo, Puerto Rico. Once the dispensary passes inspection and the Department of Health of Puerto Rico issues the requisite Occupational License for Establishment, the Company will be ready to begin operations in Fajardo. 
Read more

Scythian Biosciences Closes Strategic Sale of Latin American and Caribbean Assets

Scythian Biosciences Closes Strategic Sale of Latin American and Caribbean Assets
TORONTO, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE: SCYB) (Frankfurt: 9SB) (OTC – Nasdaq Intl: SCCYF) has closed its strategic sale of the Company’s Latin American and Caribbean assets to Aphria Inc. (TSX:APH) (“Aphria”), a leading global cannabis company. This sale will provide Scythian with leverage for early stage investments in emerging U.S. markets.
Read more

Aphria plans for global cannabis leadership with international expansion acquiring leading assets in Latin America and the Caribbean

Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) is proud to announce the Company's planned expansion into Latin America and the Caribbean with the proposed acquisition of industry-leading companies in Colombia, Argentina, Jamaica and a right of first offer and refusal in respect of Brazilthrough a definitive share purchase agreement (the "Agreement") with Scythian Biosciences Inc. ("Scythian"). Aphria will acquire 100% of the issued and outstanding common shares of LATAM Holdings Inc. ("LATAM Holdings"), a direct, wholly-owned subsidiary of Scythian (collectively, the "Transaction").
Read more